Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings

Early-Phase Adverse Effects and Management of Liposomal Amikacin Inhalation for Refractory Mycobacterium avium Complex Lung Disease in Real-World Settings

Atsuho Morita,1 Ho Namkoong,2 Kazuma Yagi,1 Takanori Asakura,1 Makoto Hosoya,3 Hiromu Tanaka,1 Ho Lee,1 Takunori Ogawa,1 Tatsuya Kusumoto,1 Shuhei Azekawa,1 Kensuke Nakagawara,1 Hirofumi Kamata,1 Makoto Ishii,1 Koichi Fukunaga,1 Hiroyuki Ozawa,3 Naoki Hasegawa2 1Division of Pulmonary Medicine, Depar...

Full description

Bibliographic Details
Main Authors: Morita A, Namkoong H, Yagi K, Asakura T, Hosoya M, Tanaka H, Lee H, Ogawa T, Kusumoto T, Azekawa S, Nakagawara K, Kamata H, Ishii M, Fukunaga K, Ozawa H, Hasegawa N
Format: Article
Language:English
Published: Dove Medical Press 2022-07-01
Series:Infection and Drug Resistance
Subjects:
mycobacterium avium complex
mac
nontuberculous mycobacteria
ntm
amikacin liposome inhalation suspension
alis
Online Access:https://www.dovepress.com/early-phase-adverse-effects-and-management-of-liposomal-amikacin-inhal-peer-reviewed-fulltext-article-IDR

Internet

https://www.dovepress.com/early-phase-adverse-effects-and-management-of-liposomal-amikacin-inhal-peer-reviewed-fulltext-article-IDR

Similar Items